The European Union and United States have finalised a trade agreement cantered around a 15% tariff on goods from Europe, reports RTE.
The specifics of the deal are crucial.
Past negotiations have nearly reached completion but were abruptly halted by the White House — a risk that still remains.
From what has been revealed so far, the deal would feature a standard 15% tariff, reports RTE.
Several existing duties would be absorbed into this unified rate, effectively making it a comprehensive tariff. For instance, it would encompass the “most favoured nation” 4.8% duties that currently apply under World Trade Organization guidelines.
Nevertheless, certain tariffs would not be rolled in. The 50% levy on steel and aluminum, which was implemented by former US President Donald Trump on EU exports, is expected to stay in place, reports RTE.
It appears the deal may ultimately eliminate the looming threat of 30% tariffs on EU imports that were due to kick in on 1 August.
Tánaiste Simon Harris has said he remains “cautiously optimistic” that an agreement can be secured for a “positive future EU-US trading relationship within the coming days”, reports RTE.
He adds: “It is now long past time to strike a deal,” reports RTE.
As per the proposed framework, the US would begin with some immediate actions, though other elements would still require further negotiation.
In encouraging news for Irish exporters, it looks likely that aircraft, medical equipment, and alcoholic beverages will fall under a mutual zero-tariff arrangement, reports RTE.
The major concern for Ireland lies with its exports of pharmaceuticals and microchips to the US.
Currently, no tariffs apply to those sectors while the US conducts a national security review into such imports.
However, it appears that the outcome of the investigation might see a 15% tariff imposed on pharmaceuticals and computer chips exported from the EU, reports RTE.
Such a tariff would have major repercussions.
Pharmaceuticals are Ireland’s largest export to the US, valued at €44 billion in the past year.
Companies hit with a new tariff will need to determine how to absorb the added cost, reports RTE.
They’ll be considering internal cost reductions, possible supply chain changes, or whether the additional costs can be passed on to their buyers.
Donald Trump remarked to Taoiseach Micheál Martin on St Patrick’s Day that Ireland “took” American pharmaceutical companies, reports RTE.
Despite Mr Trump’s remarks, no US pharmaceutical firm operating in Ireland has so far indicated plans to relocate back to the United States.
A 15% flat tariff would carry significant implications for numerous businesses, reports RTE.
Simon McKeever, head of the Irish Exporters Association, said his group will advocate for a “tariff adjustment fund”, drawing inspiration from the €1bn Brexit Reserve Fund used to support firms after the UK left the EU.
Even if an agreement is reached, the trading terms would still be less favorable than what Irish businesses had last year.
For a small, export-driven country like Ireland, tariffs present a major economic challenge, reports RTE.
The worldwide reduction of trade barriers in recent decades has lifted millions in poorer nations out of poverty.
Yet the most damaging aspect of this trade conflict is the severe uncertainty it has caused, leading many companies to delay or cancel investment plans in Ireland and beyond, reports RTE.
The certainty of the new deal could prompt the release of delayed investments.
Tell us your thoughts in the Facebook post and share this with your friends.
